[
  {
    "ts": null,
    "headline": "DexCom Expands G7 And Stelo To Deepen CGM Ecosystem Engagement",
    "summary": "DexCom (NasdaqGS:DXCM) has begun a broad U.S. rollout of its G7 15-day continuous glucose monitoring system, extending sensor wear time for users. The company is preparing a nationwide release of AI-enabled upgrades to its Stelo platform, aimed at providing deeper nutritional insights and personalized metabolic health guidance. These product moves expand DexCom's presence in diabetes and metabolic health management and introduce new data driven tools for everyday decision making. DexCom...",
    "url": "https://finnhub.io/api/news?id=d18c6a4a5be02a8cc9ff58c892b84b992c19c326e29289c83b1e496dd3dd3a9c",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1771020536,
      "headline": "DexCom Expands G7 And Stelo To Deepen CGM Ecosystem Engagement",
      "id": 139091277,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "DXCM",
      "source": "Yahoo",
      "summary": "DexCom (NasdaqGS:DXCM) has begun a broad U.S. rollout of its G7 15-day continuous glucose monitoring system, extending sensor wear time for users. The company is preparing a nationwide release of AI-enabled upgrades to its Stelo platform, aimed at providing deeper nutritional insights and personalized metabolic health guidance. These product moves expand DexCom's presence in diabetes and metabolic health management and introduce new data driven tools for everyday decision making. DexCom...",
      "url": "https://finnhub.io/api/news?id=d18c6a4a5be02a8cc9ff58c892b84b992c19c326e29289c83b1e496dd3dd3a9c"
    }
  },
  {
    "ts": null,
    "headline": "Top S&P500 movers in Friday's session",
    "summary": "Wondering what's happening in today's session for the S&P500 index? Stay informed with the top movers within the S&P500 index on Friday.",
    "url": "https://finnhub.io/api/news?id=e949128c1a554c67a72000917615d4af2652de36980c1eec7865a1bb6bba1f45",
    "source": "ChartMill",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1771013110,
      "headline": "Top S&P500 movers in Friday's session",
      "id": 139088340,
      "image": "https://www.chartmill.com/images/uploads/CM_Top_Movers_Small_free_2b4ff2fc22.webp",
      "related": "DXCM",
      "source": "ChartMill",
      "summary": "Wondering what's happening in today's session for the S&P500 index? Stay informed with the top movers within the S&P500 index on Friday.",
      "url": "https://finnhub.io/api/news?id=e949128c1a554c67a72000917615d4af2652de36980c1eec7865a1bb6bba1f45"
    }
  },
  {
    "ts": null,
    "headline": "Friday's session: top gainers and losers in the S&P500 index",
    "summary": "Uncover the latest developments among S&P500 stocks in today's session. Stay tuned to the S&P500 index's top gainers and losers on Friday.",
    "url": "https://finnhub.io/api/news?id=a6d5fbb65e7b62b55258f7d99ecaac863967df635c2e772fcb62bacc5dbfaf72",
    "source": "ChartMill",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1771004109,
      "headline": "Friday's session: top gainers and losers in the S&P500 index",
      "id": 139086377,
      "image": "https://www.chartmill.com/images/uploads/CM_Top_Movers_Small_free_2b4ff2fc22.webp",
      "related": "DXCM",
      "source": "ChartMill",
      "summary": "Uncover the latest developments among S&P500 stocks in today's session. Stay tuned to the S&P500 index's top gainers and losers on Friday.",
      "url": "https://finnhub.io/api/news?id=a6d5fbb65e7b62b55258f7d99ecaac863967df635c2e772fcb62bacc5dbfaf72"
    }
  },
  {
    "ts": null,
    "headline": "DexCom Stock Falls Despite Q4 Earnings Beat, G7 Rollout Drives Growth",
    "summary": "DXCM beats Q4 EPS estimates, posts 13% revenue growth and reiterates 2026 guidance as G7 15 Day rollout and margin gains drive momentum.",
    "url": "https://finnhub.io/api/news?id=ec00ddad5df5606f409323120561870061fbc92c05250ce705d51d71b0b5f41a",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1771004100,
      "headline": "DexCom Stock Falls Despite Q4 Earnings Beat, G7 Rollout Drives Growth",
      "id": 139088097,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "DXCM",
      "source": "Yahoo",
      "summary": "DXCM beats Q4 EPS estimates, posts 13% revenue growth and reiterates 2026 guidance as G7 15 Day rollout and margin gains drive momentum.",
      "url": "https://finnhub.io/api/news?id=ec00ddad5df5606f409323120561870061fbc92c05250ce705d51d71b0b5f41a"
    }
  },
  {
    "ts": null,
    "headline": "Dexcom reports 2025 revenues of $4.66bn yet 2026 outlook lags analyst expectations",
    "summary": "Dexcom's 2026 revenue estimates lagged analysts' expectations, according to data compiled by the London Stock Exchange Group (LSEG).",
    "url": "https://finnhub.io/api/news?id=ec7a1e0f00d2f59c42c2ad2ce19471e61c5e4093c942b615b4407383a895c186",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1771002645,
      "headline": "Dexcom reports 2025 revenues of $4.66bn yet 2026 outlook lags analyst expectations",
      "id": 139086803,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "DXCM",
      "source": "Yahoo",
      "summary": "Dexcom's 2026 revenue estimates lagged analysts' expectations, according to data compiled by the London Stock Exchange Group (LSEG).",
      "url": "https://finnhub.io/api/news?id=ec7a1e0f00d2f59c42c2ad2ce19471e61c5e4093c942b615b4407383a895c186"
    }
  },
  {
    "ts": null,
    "headline": "Why Is DexCom (DXCM) Stock Rocketing Higher Today",
    "summary": "Shares of medical device company DexCom (NASDAQ:DXCM) jumped 7.3% in the morning session after it reported better-than-expected fourth-quarter 2025 financial results, beating analyst estimates for both revenue and earnings.",
    "url": "https://finnhub.io/api/news?id=17f81d86196daf32be47d8b28c00fab1567b5621f084e2f7328bb8948cf18b76",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1771000269,
      "headline": "Why Is DexCom (DXCM) Stock Rocketing Higher Today",
      "id": 139086804,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "DXCM",
      "source": "Yahoo",
      "summary": "Shares of medical device company DexCom (NASDAQ:DXCM) jumped 7.3% in the morning session after it reported better-than-expected fourth-quarter 2025 financial results, beating analyst estimates for both revenue and earnings.",
      "url": "https://finnhub.io/api/news?id=17f81d86196daf32be47d8b28c00fab1567b5621f084e2f7328bb8948cf18b76"
    }
  },
  {
    "ts": null,
    "headline": "Small Caps, Silver Rally As Inflation Cools Further: What's Moving Markets Friday?",
    "summary": "After Thursday&#39;s broad-based tech selloff, Wall Street staged a rebound as a softer-than-expected inflation print reinforced expectations for interest-rate cuts during the year.",
    "url": "https://finnhub.io/api/news?id=c6704b4bd9dc180539b1d0d09aeeb565592b13c81183554675bbfe80fcbac388",
    "source": "Benzinga",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770994125,
      "headline": "Small Caps, Silver Rally As Inflation Cools Further: What's Moving Markets Friday?",
      "id": 139095442,
      "image": "https://cdn.benzinga.com/files/images/story/2026/02/13/Concept-Of-Small-Cap-Write-On-Sticky-Not.jpeg?width=2048&height=1536",
      "related": "DXCM",
      "source": "Benzinga",
      "summary": "After Thursday&#39;s broad-based tech selloff, Wall Street staged a rebound as a softer-than-expected inflation print reinforced expectations for interest-rate cuts during the year.",
      "url": "https://finnhub.io/api/news?id=c6704b4bd9dc180539b1d0d09aeeb565592b13c81183554675bbfe80fcbac388"
    }
  },
  {
    "ts": null,
    "headline": "DexCom, Inc. Q4 2025 Earnings Call Summary",
    "summary": "Moby summary of DexCom, Inc.'s Q4 2025 earnings call",
    "url": "https://finnhub.io/api/news?id=cf0010be50b654a4e4533c3a65d2cf406110af61be9acd12a0120e23b338321c",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770989400,
      "headline": "DexCom, Inc. Q4 2025 Earnings Call Summary",
      "id": 139092679,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "DXCM",
      "source": "Yahoo",
      "summary": "Moby summary of DexCom, Inc.'s Q4 2025 earnings call",
      "url": "https://finnhub.io/api/news?id=cf0010be50b654a4e4533c3a65d2cf406110af61be9acd12a0120e23b338321c"
    }
  },
  {
    "ts": null,
    "headline": "Stocks making the biggest moves midday: Moderna, Instacart, Rivian Automotive, DraftKings, Coinbase & more",
    "summary": "Here are some of the biggest movers in midday trading.",
    "url": "https://finnhub.io/api/news?id=eecc84f88376a879caba590388a99eeee0c807fb6f8e4df6feabcb32937d19dc",
    "source": "CNBC",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770986770,
      "headline": "Stocks making the biggest moves midday: Moderna, Instacart, Rivian Automotive, DraftKings, Coinbase & more",
      "id": 139086408,
      "image": "https://image.cnbcfm.com/api/v1/image/108179666-1753963608092-gettyimages-2219723511-s3___bgmp-arc_arc-feeds_generic-photos_to-arc_ryanmoderna4bi.jpeg?v=1771004067&w=1920&h=1080",
      "related": "DXCM",
      "source": "CNBC",
      "summary": "Here are some of the biggest movers in midday trading.",
      "url": "https://finnhub.io/api/news?id=eecc84f88376a879caba590388a99eeee0c807fb6f8e4df6feabcb32937d19dc"
    }
  },
  {
    "ts": null,
    "headline": "Dexcom seeks expanded Medicare coverage of CGMs for Type 2 diabetes",
    "summary": "New CEO Jake Leach said the company plans a trial readout in mid-2026 to support coverage of its glucose sensors in Type 2 users who don’t take insulin.",
    "url": "https://finnhub.io/api/news?id=a8d5311ca46ea0df78c9b715a7119ad5b2467c15722e8b446ac1bfebd7d30f2d",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770982728,
      "headline": "Dexcom seeks expanded Medicare coverage of CGMs for Type 2 diabetes",
      "id": 139086805,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "DXCM",
      "source": "Yahoo",
      "summary": "New CEO Jake Leach said the company plans a trial readout in mid-2026 to support coverage of its glucose sensors in Type 2 users who don’t take insulin.",
      "url": "https://finnhub.io/api/news?id=a8d5311ca46ea0df78c9b715a7119ad5b2467c15722e8b446ac1bfebd7d30f2d"
    }
  },
  {
    "ts": null,
    "headline": "Barclays Maintains Underweight on DexCom, Raises Price Target to $72",
    "summary": "Barclays  analyst Matt Miksic   maintains DexCom (NASDAQ:DXCM) with a Underweight and raises the price target from $71 to $72.",
    "url": "https://finnhub.io/api/news?id=6f18080c3edc3705fbf01cb67a0c9e7583c0495dc266acaec724c63cc66fe216",
    "source": "Benzinga",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770982444,
      "headline": "Barclays Maintains Underweight on DexCom, Raises Price Target to $72",
      "id": 139095644,
      "image": "",
      "related": "DXCM",
      "source": "Benzinga",
      "summary": "Barclays  analyst Matt Miksic   maintains DexCom (NASDAQ:DXCM) with a Underweight and raises the price target from $71 to $72.",
      "url": "https://finnhub.io/api/news?id=6f18080c3edc3705fbf01cb67a0c9e7583c0495dc266acaec724c63cc66fe216"
    }
  },
  {
    "ts": null,
    "headline": "Coinbase, Rivian Automotive, Instacart, HubSpot And Other Big Stocks Moving Higher On Friday",
    "summary": "",
    "url": "https://finnhub.io/api/news?id=0d324a8d40a99fbaf19061123163cac55822db947af7b9ebe899066718c4f369",
    "source": "Benzinga",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770982036,
      "headline": "Coinbase, Rivian Automotive, Instacart, HubSpot And Other Big Stocks Moving Higher On Friday",
      "id": 139095468,
      "image": "https://cdn.benzinga.com/files/images/story/2026/02/13/Germany---April-19-2024-Coinbase-Mobile-.jpeg?width=2048&height=1536",
      "related": "DXCM",
      "source": "Benzinga",
      "summary": " ",
      "url": "https://finnhub.io/api/news?id=0d324a8d40a99fbaf19061123163cac55822db947af7b9ebe899066718c4f369"
    }
  },
  {
    "ts": null,
    "headline": "Wells Fargo Maintains Overweight on DexCom, Lowers Price Target to $85",
    "summary": "Wells Fargo  analyst Larry Biegelsen   maintains DexCom (NASDAQ:DXCM) with a Overweight and lowers the price target from $93 to $85.",
    "url": "https://finnhub.io/api/news?id=5746d84adff09a3e0e307c6c822a0b3ac6730d7687cf869c8eca6eab8a31945b",
    "source": "Benzinga",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770979288,
      "headline": "Wells Fargo Maintains Overweight on DexCom, Lowers Price Target to $85",
      "id": 139095646,
      "image": "",
      "related": "DXCM",
      "source": "Benzinga",
      "summary": "Wells Fargo  analyst Larry Biegelsen   maintains DexCom (NASDAQ:DXCM) with a Overweight and lowers the price target from $93 to $85.",
      "url": "https://finnhub.io/api/news?id=5746d84adff09a3e0e307c6c822a0b3ac6730d7687cf869c8eca6eab8a31945b"
    }
  },
  {
    "ts": null,
    "headline": "Mizuho Maintains Outperform on DexCom, Raises Price Target to $90",
    "summary": "Mizuho  analyst Anthony Petrone   maintains DexCom (NASDAQ:DXCM) with a Outperform and raises the price target from $78 to $90.",
    "url": "https://finnhub.io/api/news?id=26c57dea2076c947770182f17208c6ffaec63c648f9e966045a0a30d38480539",
    "source": "Benzinga",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770975385,
      "headline": "Mizuho Maintains Outperform on DexCom, Raises Price Target to $90",
      "id": 139081047,
      "image": "",
      "related": "DXCM",
      "source": "Benzinga",
      "summary": "Mizuho  analyst Anthony Petrone   maintains DexCom (NASDAQ:DXCM) with a Outperform and raises the price target from $78 to $90.",
      "url": "https://finnhub.io/api/news?id=26c57dea2076c947770182f17208c6ffaec63c648f9e966045a0a30d38480539"
    }
  },
  {
    "ts": null,
    "headline": "7 Analysts Have This To Say About DexCom",
    "summary": "",
    "url": "https://finnhub.io/api/news?id=2795c31d494aab598ea9c3e5db6657f7bd56afd9f457f864caf663077b846d78",
    "source": "Benzinga",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770969666,
      "headline": "7 Analysts Have This To Say About DexCom",
      "id": 139081048,
      "image": "https://cdn.benzinga.com/files/images/story/2025/11/06/analyst_ratings_3.jpg?width=2048&height=1536",
      "related": "DXCM",
      "source": "Benzinga",
      "summary": " ",
      "url": "https://finnhub.io/api/news?id=2795c31d494aab598ea9c3e5db6657f7bd56afd9f457f864caf663077b846d78"
    }
  },
  {
    "ts": null,
    "headline": "DXCM Q4 Deep Dive: New Product Launches and International Strategy Drive Outlook",
    "summary": "Medical device company DexCom (NASDAQ:DXCM) reported Q4 CY2025 results beating Wall Street’s revenue expectations, with sales up 13.1% year on year to $1.26 billion. The company expects the full year’s revenue to be around $5.21 billion, close to analysts’ estimates. Its non-GAAP profit of $0.68 per share was 4.5% above analysts’ consensus estimates.",
    "url": "https://finnhub.io/api/news?id=1de522b8ed4e3747d2d1f61292785917631e4c01cb64dcd5789374091ab4e73a",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770960924,
      "headline": "DXCM Q4 Deep Dive: New Product Launches and International Strategy Drive Outlook",
      "id": 139085273,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "DXCM",
      "source": "Yahoo",
      "summary": "Medical device company DexCom (NASDAQ:DXCM) reported Q4 CY2025 results beating Wall Street’s revenue expectations, with sales up 13.1% year on year to $1.26 billion. The company expects the full year’s revenue to be around $5.21 billion, close to analysts’ estimates. Its non-GAAP profit of $0.68 per share was 4.5% above analysts’ consensus estimates.",
      "url": "https://finnhub.io/api/news?id=1de522b8ed4e3747d2d1f61292785917631e4c01cb64dcd5789374091ab4e73a"
    }
  },
  {
    "ts": null,
    "headline": "DexCom Inc (DXCM) Q4 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic Expansions",
    "summary": "DexCom Inc (DXCM) reports a 13% revenue increase, unveils strategic plans for international growth, and anticipates future challenges in expanding coverage for type 2 non-insulin users.",
    "url": "https://finnhub.io/api/news?id=0522cff875d74f5282f673cf8b302f2e4a3a9365832b0e448ea7c87a80c4aa1c",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770959080,
      "headline": "DexCom Inc (DXCM) Q4 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic Expansions",
      "id": 139078173,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "DXCM",
      "source": "Yahoo",
      "summary": "DexCom Inc (DXCM) reports a 13% revenue increase, unveils strategic plans for international growth, and anticipates future challenges in expanding coverage for type 2 non-insulin users.",
      "url": "https://finnhub.io/api/news?id=0522cff875d74f5282f673cf8b302f2e4a3a9365832b0e448ea7c87a80c4aa1c"
    }
  }
]